116 related articles for article (PubMed ID: 96136)
21. Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patients.
Allain JP; Gaillandre A; Lee H
J Lab Clin Med; 1981 Jun; 97(6):791-800. PubMed ID: 6785371
[TBL] [Abstract][Full Text] [Related]
22. Preferential use of lambda L chain in lamin B autoantibodies.
Reeves WH; Ali SA
J Immunol; 1989 Dec; 143(11):3614-8. PubMed ID: 2511246
[TBL] [Abstract][Full Text] [Related]
23. Thrombin-independent activation of platelet factor XIII by endogenous platelet acid protease.
Lynch GW; Pfueller SL
Thromb Haemost; 1988 Jun; 59(3):372-7. PubMed ID: 2903573
[TBL] [Abstract][Full Text] [Related]
24. Autoantibody selectively inhibits binding of von Willebrand factor to glycoprotein ib. Recognition site is located in the A1 loop of von Willebrand factor.
Mohri H; Yamazaki E; Suzuki Z; Takano T; Yokota S; Okubo T
Thromb Haemost; 1997 Apr; 77(4):760-6. PubMed ID: 9134656
[TBL] [Abstract][Full Text] [Related]
25. Intracranial hemorrhage in systemic lupus erythematosus associated with an autoantibody against actor XIII.
Lorand L; Velasco PT; Hill JM; Hoffmeister KJ; Kaye FJ
Thromb Haemost; 2002 Dec; 88(6):919-23. PubMed ID: 12529739
[TBL] [Abstract][Full Text] [Related]
26. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.
Berruyer M; Amiral J; Ffrench P; Belleville J; Bastien O; Clerc J; Kassir A; Estanove S; Dechavanne M
J Thorac Cardiovasc Surg; 1993 May; 105(5):892-7. PubMed ID: 8487567
[TBL] [Abstract][Full Text] [Related]
27. Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality.
Millward A; Hussain MJ; Peakman M; Pyke DA; Leslie RD; Vergani D
Clin Exp Immunol; 1988 Feb; 71(2):353-6. PubMed ID: 3127094
[TBL] [Abstract][Full Text] [Related]
28. Immunological studies of coagulation factor XIII.
Israels ED; Paraskevas F; Israels LG
J Clin Invest; 1973 Oct; 52(10):2398-403. PubMed ID: 4199604
[TBL] [Abstract][Full Text] [Related]
29. Autoantibody to von Willebrand factor in systemic lupus erythematosus.
Soff GA; Green D
J Lab Clin Med; 1993 Mar; 121(3):424-30. PubMed ID: 8445290
[TBL] [Abstract][Full Text] [Related]
30. [Acquired inhibitors to coagulation factors].
Okamura T
Rinsho Byori; 1994 Jan; 42(1):3-8. PubMed ID: 8107280
[TBL] [Abstract][Full Text] [Related]
31. Three M components IgA lambda, + IgG kappa n + IgG kappa h in one patient. II. Structurally different kappa n and kappa h chains associated with H(gamma) chains sharing idiotypic determinants.
Bouvet JP; Liacopoulos P; Pillot J; Banda R; Tung E; Wang AC
J Immunol; 1982 Oct; 129(4):1519-24. PubMed ID: 6180014
[TBL] [Abstract][Full Text] [Related]
32. Three M-components IgA lambda + IgG kappa n + IgG kappa h in one patient (DA): lack of shared idiotypic determinants between IgA and IgG, and the presence of an unusual kappa h chain of 30,000 M.W.
Bouvet JP; Liacopoulos P; Pillot J; Banda R; Tung E; Wang AC
J Immunol; 1980 Jul; 125(1):213-20. PubMed ID: 6769997
[TBL] [Abstract][Full Text] [Related]
33. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
Reed GL; Matsueda GR; Haber E
Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
[TBL] [Abstract][Full Text] [Related]
34. Determinants of substrate specificity for factor XIII.
McDonagh J; Fukue H
Semin Thromb Hemost; 1996; 22(5):369-76. PubMed ID: 8989819
[TBL] [Abstract][Full Text] [Related]
35. A biclonal origin of two monoclonal proteins, IgG3(kappa) and IgA1(lambda), from a single patient.
Ockhuizen T; Steen G; Muilerman HG; Smit JW; Wietzes P; Mandema E; Marrink J
Immunology; 1979 Aug; 37(4):863-8. PubMed ID: 115782
[TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of factor VII inhibitor found in a patient with life threatening bleeding.
Kamikubo Y; Miyamoto S; Iwasa A; Ishii M; Okajima K
Thromb Haemost; 2000 Jan; 83(1):60-4. PubMed ID: 10669156
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune Hemorrhaphilia Resulting from Autoantibody against the A Subunit of Factor XIII.
Uchida E; Watanabe K; Arai R; Yamamoto M; Souri M; Osaki T; Ichinose A; Miura O; Koyama T
Intern Med; 2015; 54(18):2383-7. PubMed ID: 26370866
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency.
Ishida F; Okubo K; Ito T; Okumura N; Souri M; Ichinose A
Thromb Haemost; 2010 Dec; 104(6):1284-5. PubMed ID: 20941461
[No Abstract] [Full Text] [Related]
39. [Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma].
Ueno S; Nozaki J; Kusano S; Kawano Y; Kikukawa Y; Okuno Y; Hata H; Matsuoka M; Uchiba M
Rinsho Ketsueki; 2019; 60(10):1443-1448. PubMed ID: 31695005
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patients.
Ichinose A;
Blood Rev; 2017 Jan; 31(1):37-45. PubMed ID: 27542511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
